CXCL12–CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy

Seema Singh(USA Mitchell Cancer Institute), Ajay P. Singh(USA Mitchell Cancer Institute)

British Journal of Cancer

November 1, 2010

10.1038/sj.bjc.6605968

Cited by 221

Related Papers

Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK

|British Journal of Cancer|2017|257

An Undesired Effect of Chemotherapy

|Journal of Biological Chemistry|2013|164

Honokiol Arrests Cell Cycle, Induces Apoptosis, and Potentiates the Cytotoxic Effect of Gemcitabine in Human Pancreatic Cancer Cells

|PLoS ONE|2011|132

CXCL12/CXCR4 Protein Signaling Axis Induces Sonic Hedgehog Expression in Pancreatic Cancer Cells via Extracellular Regulated Kinase- and Akt Kinase-mediated Activation of Nuclear Factor κB

|Journal of Biological Chemistry|2012|121

p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-κB pathway

|Oncotarget|2014|121